• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恒河猴主要组织相容性复合体I类分子(Mamu - A*01)的肽结合基序的特征分析,该分子可结合来自猿猴免疫缺陷病毒的免疫显性细胞毒性T淋巴细胞表位。

Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.

作者信息

Allen T M, Sidney J, del Guercio M F, Glickman R L, Lensmeyer G L, Wiebe D A, DeMars R, Pauza C D, Johnson R P, Sette A, Watkins D I

机构信息

Wisconsin Regional Primate Research Center, University of Wisconsin, Madison 53715, USA.

出版信息

J Immunol. 1998 Jun 15;160(12):6062-71.

PMID:9637523
Abstract

The majority of immunogenic CTL epitopes bind to MHC class I molecules with high affinity. However, peptides longer or shorter than the optimal epitope rarely bind with high affinity. Therefore, identification of optimal CTL epitopes from pathogens may ultimately be critical for inducing strong CTL responses and developing epitope-based vaccines. The SIV-infected rhesus macaque is an excellent animal model for HIV infection of humans. Although a number of CTL epitopes have been mapped in SIV-infected rhesus macaques, the optimal epitopes have not been well defined, and their anchor residues are unknown. We have now defined the optimal SIV gag CTL epitope restricted by the rhesus MHC class I molecule Mamu-A01 and defined a general peptide binding motif for this molecule that is characterized by a dominant position 3 anchor (proline). We used peptide elution and sequencing, peptide binding assays, and bulk and clonal CTL assays to demonstrate that the optimal Mamu-A01-restricted SIV gag CTL epitope was CTPYDINQM(181-189). Mamu-A01 is unique in that it is found at a high frequency in rhesus macaques, and all SIV-infected Mamu-A01-positive rhesus macaques studied to date develop an immunodominant gag-specific CTL response restricted by this molecule. Identification of the optimal SIV gag CTL epitope will be critical for a variety of studies designed to induce CD8+ CTL responses specific for SIV in the rhesus macaque.

摘要

大多数具有免疫原性的细胞毒性T淋巴细胞(CTL)表位与主要组织相容性复合体(MHC)I类分子具有高亲和力结合。然而,比最佳表位更长或更短的肽很少以高亲和力结合。因此,从病原体中鉴定最佳CTL表位可能最终对于诱导强烈的CTL反应和开发基于表位的疫苗至关重要。感染猴免疫缺陷病毒(SIV)的恒河猴是人类感染HIV的优秀动物模型。尽管在感染SIV的恒河猴中已经定位了许多CTL表位,但最佳表位尚未得到很好的定义,其锚定残基也未知。我们现在已经确定了受恒河猴MHC I类分子Mamu-A01限制的最佳SIV gag CTL表位,并确定了该分子的一般肽结合基序,其特征是在第3位有一个占主导地位的锚定残基(脯氨酸)。我们使用肽洗脱和测序、肽结合试验以及大量和克隆CTL试验来证明最佳的受Mamu-A01限制的SIV gag CTL表位是CTPYDINQM(181-189)。Mamu-A01的独特之处在于它在恒河猴中高频出现,并且迄今为止研究的所有感染SIV的Mamu-A01阳性恒河猴都产生了受该分子限制的免疫显性gag特异性CTL反应。鉴定最佳SIV gag CTL表位对于旨在在恒河猴中诱导针对SIV的特异性CD8+ CTL反应的各种研究至关重要。

相似文献

1
Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.恒河猴主要组织相容性复合体I类分子(Mamu - A*01)的肽结合基序的特征分析,该分子可结合来自猿猴免疫缺陷病毒的免疫显性细胞毒性T淋巴细胞表位。
J Immunol. 1998 Jun 15;160(12):6062-71.
2
Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.受MHC I类分子Mamu - B*01限制的新型猿猴免疫缺陷病毒CTL表位在经DNA/MVA疫苗接种并受到SHIV攻击的恒河猴中长期高度保守。
Int Immunol. 2005 May;17(5):637-48. doi: 10.1093/intimm/dxh245. Epub 2005 Apr 11.
3
Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus.对感染猿猴免疫缺陷病毒的猕猴体内CD8 + T细胞反应的直接测量。
Virology. 2000 Jul 5;272(2):347-56. doi: 10.1006/viro.2000.0404.
4
CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing.来自感染猿猴免疫缺陷病毒的恒河猴的CD8(+)淋巴细胞识别由主要组织相容性复合体I类分子Mamu-A*01结合的14种不同表位:对疫苗设计和测试的意义。
J Virol. 2001 Jan;75(2):738-49. doi: 10.1128/JVI.75.2.738-749.2001.
5
Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?在由高频主要组织相容性复合体I类分子Mamu - A*02结合的两种细胞毒性T淋巴细胞表位之一中逃逸:病毒进化与持续存在的范例?
J Virol. 2002 Nov;76(22):11623-36. doi: 10.1128/jvi.76.22.11623-11636.2002.
6
Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag.细胞毒性T淋巴细胞似乎不会选择猿猴免疫缺陷病毒gag免疫显性表位中的突变。
J Immunol. 1992 Dec 15;149(12):4060-6.
7
Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition.鉴定出17个由高频分子Mamu - A*02限制的新的猿猴免疫缺陷病毒衍生的CD8 + T细胞表位以及潜在的CTL识别逃逸情况。
J Immunol. 2004 Oct 15;173(8):5064-76. doi: 10.4049/jimmunol.173.8.5064.
8
A simian immunodeficiency virus nef peptide is a dominant cytotoxic T lymphocyte epitope in Indian-origin rhesus monkeys expressing the common MHC class I allele mamu-A*02.一种猿猴免疫缺陷病毒nef肽是表达常见MHC I类等位基因mamu - A*02的印度恒河猴中的主要细胞毒性T淋巴细胞表位。
Virology. 2002 Sep 30;301(2):365-73. doi: 10.1006/viro.2002.1598.
9
Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses during primary simian immunodeficiency virus infection in Burmese rhesus macaques.在缅甸猕猴原发性猴免疫缺陷病毒感染期间,主要组织相容性复合体 I 类限制的细胞毒性 T 淋巴细胞反应。
Microbiol Immunol. 2011 Nov;55(11):768-73. doi: 10.1111/j.1348-0421.2011.00384.x.
10
Rapid screening for Mamu-A1-positive rhesus macaques using a SIVmac Gag peptide-specific cytotoxic T-lymphocyte assay.使用SIVmac Gag肽特异性细胞毒性T淋巴细胞检测法对Mamu-A1阳性恒河猴进行快速筛查。
Immunology. 1995 Mar;84(3):482-7.

引用本文的文献

1
Modifications to rhesus macaque TCR constant regions improve TCR cell surface expression.对恒河猴TCR恒定区的修饰可改善TCR细胞表面表达。
PLoS One. 2025 Jan 9;20(1):e0314751. doi: 10.1371/journal.pone.0314751. eCollection 2025.
2
Rhesus Cytomegalovirus-Specific CD8 Cytotoxic T Lymphocytes Do Not Become Functionally Exhausted in Chronic SIVmac239 Infection.恒河猴巨细胞病毒特异性 CD8 细胞毒性 T 淋巴细胞在慢性 SIVmac239 感染中不会发生功能衰竭。
Front Immunol. 2020 Aug 12;11:1960. doi: 10.3389/fimmu.2020.01960. eCollection 2020.
3
High-Throughput Identification of MHC Class I Binding Peptides Using an Ultradense Peptide Array.
高通量鉴定使用超密集肽阵列的 MHC Ⅰ类结合肽。
J Immunol. 2020 Mar 15;204(6):1689-1696. doi: 10.4049/jimmunol.1900889. Epub 2020 Feb 14.
4
MHC class I allele diversity in cynomolgus macaques of Vietnamese origin.越南起源食蟹猕猴的MHC I类等位基因多样性。
PeerJ. 2019 Nov 4;7:e7941. doi: 10.7717/peerj.7941. eCollection 2019.
5
A Recombinant Rhesus Monkey Rhadinovirus Deleted of Glycoprotein L Establishes Persistent Infection of Rhesus Macaques and Elicits Conventional T Cell Responses.一种缺失糖蛋白 L 的重组恒河猴疱疹病毒可建立恒河猴的持续性感染并引发常规 T 细胞应答。
J Virol. 2020 Jan 6;94(2). doi: 10.1128/JVI.01093-19.
6
Low levels of SIV-specific CD8+ T cells in germinal centers characterizes acute SIV infection.SIV 特异性 CD8+ T 细胞在生发中心的低水平是急性 SIV 感染的特征。
PLoS Pathog. 2019 Mar 21;15(3):e1007311. doi: 10.1371/journal.ppat.1007311. eCollection 2019 Mar.
7
Immunization with one Theileria parva strain results in similar level of CTL strain-specificity and protection compared to immunization with the three-component Muguga cocktail in MHC-matched animals.在 MHC 匹配的动物中,与用三分量穆古加鸡尾酒疫苗免疫相比,用一种泰勒虫小种菌株免疫可产生相似水平的细胞毒性 T 淋巴细胞菌株特异性和保护作用。
BMC Vet Res. 2018 May 2;14(1):145. doi: 10.1186/s12917-018-1460-x.
8
ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment.ALT-803在无抗逆转录病毒治疗的情况下可短暂降低猿猴免疫缺陷病毒复制。
J Virol. 2018 Jan 17;92(3). doi: 10.1128/JVI.01748-17. Print 2018 Feb 1.
9
A SIV molecular clone that targets the CNS and induces neuroAIDS in rhesus macaques.一种靶向中枢神经系统并在恒河猴中诱发神经艾滋病的猴免疫缺陷病毒分子克隆。
PLoS Pathog. 2017 Aug 7;13(8):e1006538. doi: 10.1371/journal.ppat.1006538. eCollection 2017 Aug.
10
Isolation of a monoclonal antibody from a phage display library binding the rhesus macaque MHC class I allomorph Mamu-A1*001.从噬菌体展示文库中分离出一种与恒河猴MHC I类同种异型Mamu-A1*001结合的单克隆抗体。
PLoS One. 2017 Jul 18;12(7):e0179039. doi: 10.1371/journal.pone.0179039. eCollection 2017.